An epidemic of atrial fibrillation?

Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors

(2011) Rachel R. Huxley et al.   CIRCULATION

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

(2011) Hrafnhildur Stefansdottir et al.   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs

(2010) Renato D. Lopes et al.   THROMBOSIS AND HAEMOSTASIS

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1

(2010) Laurent Gorin et al.   THROMBOSIS AND HAEMOSTASIS

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice

(2010) Gregory Lip   THROMBOSIS AND HAEMOSTASIS